Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.960
-0.020 (-0.40%)
At close: Jun 15, 2026, 4:00 PM EDT
4.900
-0.060 (-1.21%)
After-hours: Jun 15, 2026, 6:09 PM EDT
MRVI Revenue
Maravai LifeSciences Holdings had revenue of $65.84M in the quarter ending March 31, 2026, with 40.53% growth. This brings the company's revenue in the last twelve months to $204.73M, down -15.35% year-over-year. In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%.
Revenue (ttm)
$204.73M
Revenue Growth
-15.35%
P/S Ratio
6.26
Revenue / Employee
$492,139
Employees
416
Market Cap
1.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 185.74M | -73.44M | -28.34% |
| Dec 31, 2024 | 259.19M | -29.76M | -10.30% |
| Dec 31, 2023 | 288.95M | -594.06M | -67.28% |
| Dec 31, 2022 | 883.00M | 83.76M | 10.48% |
| Dec 31, 2021 | 799.24M | 515.14M | 181.33% |
| Dec 31, 2020 | 284.10M | 140.96M | 98.48% |
| Dec 31, 2019 | 143.14M | 19.31M | 15.59% |
| Dec 31, 2018 | 123.83M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 427.68M |
| Immatics | 43.00M |
| Maze Therapeutics | 20.00M |
| Zenas BioPharma | 10.00M |
| Aktis Oncology | 8.28M |
| Inhibrx Biosciences | 1.30M |
MRVI News
- 11 days ago - Maravai LifeSciences Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Maravai Lifesciences announces refinancing of credit agreement - TheFly
- 12 days ago - Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032 - Business Wire
- 4 weeks ago - Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference - Business Wire
- 5 weeks ago - Maravai Lifesciences price target raised to $6 from $4.50 at Deutsche Bank - TheFly
- 5 weeks ago - Maravai LifeSciences Holdings Slides: Investor presentation - Filings
- 5 weeks ago - Maravai LifeSciences Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Maravai LifeSciences Holdings Earnings release: Q1 2026 - Filings